Kyoto Univ. to Commence Trial of Drug Candidate Discovered in iPS Cells Research for Rare Bone Disease

Kyoto University’s Center for iPS Cell Research and Application (CiRA) said on August 1 that it will launch an investigator-initiated trial of the drug candidate rapamycin, an immunosuppressant that was identified in research using iPS Cells created from fibrodysplasia ossificans...read more